- Home
- Products
- Customized ADCs
- CD70
- Anti-CD70-MCC-DM1 ADC
Anti-CD70-MCC-DM1 ADC (CAT#: ADC-W-487)
This ADC product is comprised of an anti-CD70 monoclonal antibody conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Similar to
- AMG-172
- Name
- CD70
- Alternative Names
- CD70; CD70 molecule; CD27L; CD27LG; TNFSF7; CD70 antigen; CD27-L; CD27 ligand; Ki-24 antigen; surface antigen CD70; tumor necrosis factor ligand superfamily member 7; tumor necrosis factor (ligand) superfamily, member 7;
- Target Entrez Gene ID
- 970
- Target UniProt ID
- P32970
- Overview
- The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes. It induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.
- Overview
- Human Anti-CD70 lgG1 Antibody
- Species Reactivity
- Human
- Name
- MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
- Description
- Derived from Maytansinoid,a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGA4 (Etrolizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1475)
- Anti-CD74-SMCC-Dox ADC (CAT#: ADC-W-479)
- Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC (CAT#: ADC-W-504)
- Anti-EGFR (Panitumumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1043)
- Anti-MS4A1 (Ocrelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1579)
- Anti-RSV F (Motavizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2147)
- Anti-PCSK9 (Ralpancizumab)-SPDB-DM4 ADC (CAT#: ADC-W-2313)
- Anti-IL6 (Olokizumab)-SPDB-DM4 ADC (CAT#: ADC-W-1419)
- Anti-LTA (Pateclizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1532)
- Anti-MS4A1 (Ibritumomab)-SMCC-DM1 ADC (CAT#: ADC-W-1550)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-487. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-375 | Anti-CD70-β-glucuronide-MMAF ADC-5 | β-glucuronide linker | MMAF (Monomethyl auristatin F) |
| ADC-W-950 | Anti-CD70-SMCC-DM1 ADC-7 | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-471 | Anti-CD70-VC-MED-2460-ADC | VC (valine-citrulline) | MED-2460 |
| ADC-W-952 | Anti-CD70-MC-MMAF ADC-7 | MC (maleimidocaproyl) | MMAF |
| ADC-W-451 | Anti-CD70-Mc-VC-PABC-MMAF ADC-1 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-512 | Anti-ERBB2-SMCC-maytansine ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | maytansine |
| ADC-W-578 | Anti-CD74-MCC-Dox ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | doxorubicin |
| ADC-W-614 | Anti-CD19-MCC-DM1 ADC-5 | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-484 | Anti-CD22-MCC-DM1 ADC-11 | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-AA-054 | Protein A-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-026 | anti-MIgG(Fc)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-AA-008 | anti-HIgG(Fc)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-495 | Anti-EGFR-SMCC-DM1 ADC-4 | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-582 | Anti-ERBB2-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-AA-031 | anti-MIgG(Fc)Fab-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
